Inventor · disambiguated record
Wolfgang Guba
Also filed as: GUBA WOLFGANG
47 granted patents·27 pending applications·92 citations·filing 2003–2025
97Inventor score
Top patents by PatentIndex Score
74 records- 0189US10414780B2Pyridyl-triazabicyclesHOFFMANN LA ROCHE·Filed 2018·Granted Sep 17, 2019·4 cites·2 claims
- 0287US10047102B2Pyridyl-triazabicyclesHOFFMANN LA ROCHE·Filed 2015·Granted Aug 14, 2018·4 cites·16 claims
- 0386US10189848B2Ethynyl derivativesHOFFMANN LA ROCHE·Filed 2018·Granted Jan 29, 2019·4 cites·18 claims
- 0486US8420661B2Arylethynyl derivativesGREEN LUKE·Filed 2011·Granted Apr 16, 2013·8 cites·6 claims
- 0584US8389513B22-amino-5,5-difluoro-5,6-dihydro-4H-[1,3]oxazin-4-yl)-phenyl]-amidesBANNER DAVID·Filed 2010·Granted Mar 5, 2013·9 cites·31 claims
- 0683US10065956B2Ethynyl derivativesHOFFMANN LA ROCHE·Filed 2017·Granted Sep 4, 2018·4 cites·12 claims
- 0783US10047081B2BACE1 inhibitorsHOFFMANN LA ROCHE·Filed 2016·Granted Aug 14, 2018·3 cites·25 claims
- 0883US9695128B2Ethynyl derivativesHOFFMANN LA ROCHE·Filed 2016·Granted Jul 4, 2017·4 cites·8 claims
- 0983US8513273B2Arylethynyl derivativesHOFFMANN LA ROCHE·Filed 2013·Granted Aug 20, 2013·4 cites·6 claims
- 1082US9725416B2Ethynyl derivativesHOFFMANN LA ROCHE·Filed 2016·Granted Aug 8, 2017·4 cites·12 claims
- 1182US8618296B2Arylethynyl derivativesHOFFMANN LA ROCHE·Filed 2013·Granted Dec 31, 2013·4 cites·6 claims
- 1281US10723729B2BACE1 inhibitorsHOFFMANN LA ROCHE·Filed 2019·Granted Jul 28, 2020·1 cites·19 claims
- 1381US10399969B2BACE1 inhibitorsHOFFMANN LA ROCHE·Filed 2018·Granted Sep 3, 2019·2 cites·2 claims
- 1481US8716316B2Positive allosteric modulators (PAM)HOFFMANN LA ROCHE·Filed 2013·Granted May 6, 2014·4 cites·14 claims
- 1580US10246468B2BACE1 inhibitorsHOFFMANN LA ROCHE·Filed 2016·Granted Apr 2, 2019·3 cites·19 claims
- 1678US9540397B2BACE1 inhibitorsHOFFMANN LA ROCHE·Filed 2015·Granted Jan 10, 2017·2 cites·24 claims
- 1777US9315498B2Arlethynyl derivativesHOFFMANN LA ROCHE·Filed 2013·Granted Apr 19, 2016·2 cites·8 claims
- 1874US7576088B2Benzodioxole derivativesHOFFMANN LA ROCHE·Filed 2005·Granted Aug 18, 2009·2 cites·16 claims
- 1973US8815881B21,4,5,6-tetrahydro-pyrimidin-2-ylamine compoundsBANNER DAVID·Filed 2011·Granted Aug 26, 2014·1 cites·14 claims
- 2073US8673894B22,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compoundsBANNER DAVID·Filed 2011·Granted Mar 18, 2014·2 cites·17 claims
- 2173US8586581B2Ethynyl compounds useful for treatment of CNS disordersGREEN LUKE·Filed 2010·Granted Nov 19, 2013·2 cites·8 claims
- 2273US8389536B2Positive allosteric modulators (PAM)GREEN LUKE·Filed 2010·Granted Mar 5, 2013·2 cites·13 claims
- 2373US6900227B2Benzodioxole derivativesHOFFMANN LA ROCHE·Filed 2003·Granted May 31, 2005·7 cites·15 claims
- 2473US2024132471A1Novel compoundsHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 2572US12006323B2Ethynyl derivativesHOFFMANN LA ROCHE·Filed 2021·Granted Jun 11, 2024·0 cites·16 claims
- 2672US7253197B2Aminothiazole derivativesHOFFMANN LA ROCHE·Filed 2003·Granted Aug 7, 2007·5 cites·6 claims
- 2771US12421209B2CompoundsHOFFMANN LA ROCHE·Filed 2025·Granted Sep 23, 2025·0 cites·2 claims
- 2871US7645753B2Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivativesHOFFMANN LA ROCHE·Filed 2006·Granted Jan 12, 2010·1 cites·27 claims
- 2970US11034687B2BACE1 inhibitorsHOFFMANN LA ROCHE·Filed 2020·Granted Jun 15, 2021·0 cites·18 claims
- 3070US2025276958A1CompoundsHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 3169US7323466B2Morpholine derivatives as 5HT2C receptor agonists for the treatment of obesityHOFFMANN LA ROCHE·Filed 2006·Granted Jan 29, 2008·1 cites·14 claims
- 3268US10829500B2Pyridyl-triazabicyclesHOFFMANN LA ROCHE·Filed 2019·Granted Nov 10, 2020·0 cites·12 claims
- 3368US9920072B2BACE1 inhibitorsHOFFMANN LA ROCHE·Filed 2015·Granted Mar 20, 2018·1 cites·13 claims
- 3466US8748418B21,4-oxazepines as BACE1 and/or BACE2 inhibitorsGABELLIERI EMANUELE·Filed 2012·Granted Jun 10, 2014·2 cites·28 claims
- 3562US2024279237A1Fused bicyclic heteroaryl compounds useful as nlrp3 inhibitorsHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 3662US2025296931A1Novel isoquinolinone, pyrrolopyridinone and thienopyridinone sulfonamide derivativesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 3762US2024025883A1Pyrimidin-2-yl sulfonamide derivativesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 3861US11034699B2Ethynyl derivativesHOFFMANN LA ROCHE·Filed 2018·Granted Jun 15, 2021·0 cites·16 claims
- 3961US2024409553A1Heterocyclic nlrp3 inhibitorsHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 4061US2024308977A1Pyridazine derivatives as inhibitors of nlrp3HOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 4160US2014336208A11,4,5,6-tetrahydro-pyrimidin-2-ylamine compoundsHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 4259US2023234939A1Imidazole-pyrazole derivatives as antibacterialsHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 4359US2024208928A1Novel compoundsHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 4458US2009163517A1Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivativesBINGGELI ALFRED·Filed 2009·Application pending·0 cites
- 4558US2025353830A1Novel compoundsHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 4657US8933094B2Ethynyl compounds useful for treatment of CNS disorderHOFFMANN LA ROCHE·Filed 2013·Granted Jan 13, 2015·0 cites·3 claims
- 4756US2023242520A1Malonitrile derivativesHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 4856US2023242494A1Malonitrile derivativesHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 4955US12509467B2CGAS inhibiting triazolopyrimidone derivativesHOFFMANN LA ROCHE·Filed 2021·Granted Dec 30, 2025·0 cites·14 claims
- 5054US2023227411A1Benzimidazole DerivativesHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
Showing the top 50 of 74 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Wolfgang Guba files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →